investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Toxicity Monitoring on Phase III Trials with Administrative Data
Richard Aplenc
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Lillian Sung
Hospital for Sick Children
Toronto, Canada
Richard Aplenc
Children's Hospital of Philadelphia
Philadelphia, United States
Related projects
Clark W Distelhorst
Bcl-2 Function on the Endoplasmic Reticulum
Leukaemia
Hematology and hematologic malignancies
Catherine Ju-Ying Wu
(PQD1) Impact of Cytotoxic and Targeted Therapy on Clonal Evolution of CLL
Leukaemia
Hematology and hematologic malignancies
David A Fruman
TOR Kinase Inhibitors for Leukemia Therapy: Mechanisms of Action and Resistance
Leukaemia
Hematology and hematologic malignancies
Alicia S Kunin-Batson
Healthy Kids after Cancer: A Physical Activity and Nutrition Intervention
Leukaemia
Pediatric oncology or childhood cancer
James C Paulson
In vivo Targeting of Hematopoetic Cells With Glycan Ligands of Siglecs
Leukaemia
Hematology and hematologic malignancies
Kenneth C Anderson
Specialized Program of Research Excellence (SPORE) in Multple Myeloma
Leukaemia
Hematology and hematologic malignancies
Javier Adachi
Genomic Characteristics of VRE Bloodstream Infection in Patients with Hematological Malignancies: Impact on Clinical Outcomes in Six Geographical Regions
Leukaemia
Hematology and hematologic malignancies
Christopher I Li
Pediatric Oncology Research Training Program
Leukaemia
Pediatric oncology or childhood cancer
Marina Y Konopleva
Hypoxia-Selective Kinase Inhibitors for Leukemia Therapy
Leukaemia
Hematology and hematologic malignancies
